Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
Public ClinicalTrials.gov record NCT04147650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Vehicle-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution (VOS) in Subjects With Dry Eye Syndrome (DES)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Multi-Center, Phase 2/3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Voclosporin Ophthalmic Solution (0.05%, 0.10%, 0.20%) Compared to Vehicle in Subjects with Dry Eye Syndrome.
Study identification
- NCT ID
- NCT04147650
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 508 participants
Conditions and interventions
Conditions
Interventions
- 0.05% Voclosporin Ophthalmic Solution (VOS) Drug
- 0.10% VOS Drug
- 0.20% VOS Drug
- Vehicle Ophthalmic Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2019 (Actual)
- Primary completion
- Sep 17, 2020 (Actual)
- Completion
- Oct 8, 2020 (Actual)
- Last update posted
- Dec 10, 2021
2019 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aurinia Investigative Center | Newport Beach | California | 92663 | — |
| Aurinia Investigative Center | Colorado Springs | Colorado | 80907 | — |
| Aurinia Investigative Center | Louisville | Kentucky | 40206 | — |
| Aurinia Investigative Center | Lewiston | Maine | 04240 | — |
| Aurinia Investigative Center | Andover | Massachusetts | 01810 | — |
| Aurinia Investigative Center | Raynham | Massachusetts | 02767 | — |
| Aurinia Investigative Center | Cranberry Township | Pennsylvania | 16066 | — |
| Aurinia Investigative Center | Memphis | Tennessee | 38119 | — |
| Aurinia Investigative Center | Nashville | Tennessee | 37205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04147650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2021 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04147650 live on ClinicalTrials.gov.